225 related articles for article (PubMed ID: 26735910)
1. Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease.
Lemes LFN; de Andrade Ramos G; de Oliveira AS; da Silva FMR; de Castro Couto G; da Silva Boni M; Guimarães MJR; Souza INO; Bartolini M; Andrisano V; do Nascimento Nogueira PC; Silveira ER; Brand GD; Soukup O; Korábečný J; Romeiro NC; Castro NG; Bolognesi ML; Romeiro LAS
Eur J Med Chem; 2016 Jan; 108():687-700. PubMed ID: 26735910
[TBL] [Abstract][Full Text] [Related]
2. New cholinesterase inhibitors for Alzheimer's disease: Structure Activity Studies (SARs) and molecular docking of isoquinolone and azepanone derivatives.
Bacalhau P; San Juan AA; Marques CS; Peixoto D; Goth A; Guarda C; Silva M; Arantes S; Caldeira AT; Martins R; Burke AJ
Bioorg Chem; 2016 Aug; 67():1-8. PubMed ID: 27231829
[TBL] [Abstract][Full Text] [Related]
3. New potential AChE inhibitor candidates.
de Paula AA; Martins JB; dos Santos ML; Nascente Lde C; Romeiro LA; Areas TF; Vieira KS; Gambôa NF; Castro NG; Gargano R
Eur J Med Chem; 2009 Sep; 44(9):3754-9. PubMed ID: 19446931
[TBL] [Abstract][Full Text] [Related]
4. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease.
Lan JS; Hou JW; Liu Y; Ding Y; Zhang Y; Li L; Zhang T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):776-788. PubMed ID: 28585866
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of 2-acetyl-5-O-(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Wang H; Wang H; Ma Q; Han X; Ye M; Yu L; Liu W
Bioorg Med Chem Lett; 2017 Nov; 27(22):5046-5052. PubMed ID: 29033233
[TBL] [Abstract][Full Text] [Related]
8. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
[TBL] [Abstract][Full Text] [Related]
9. Novel pyridazinone derivatives as butyrylcholinesterase inhibitors.
Dundar Y; Kuyrukcu O; Eren G; Senol Deniz FS; Onkol T; Orhan IE
Bioorg Chem; 2019 Nov; 92():103304. PubMed ID: 31561108
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of Alzheimer's disease.
Xie SS; Lan JS; Wang X; Wang ZM; Jiang N; Li F; Wu JJ; Wang J; Kong LY
Bioorg Med Chem; 2016 Apr; 24(7):1528-39. PubMed ID: 26917219
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and molecular modeling of new tetrahydroacridine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
Bajda M; Jończyk J; Malawska B; Czarnecka K; Girek M; Olszewska P; Sikora J; Mikiciuk-Olasik E; Skibiński R; Gumieniczek A; Szymański P
Bioorg Med Chem; 2015 Sep; 23(17):5610-8. PubMed ID: 26242241
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.
Samadi A; de la Fuente Revenga M; Pérez C; Iriepa I; Moraleda I; Rodríguez-Franco MI; Marco-Contelles J
Eur J Med Chem; 2013 Sep; 67():64-74. PubMed ID: 23838422
[TBL] [Abstract][Full Text] [Related]
15. Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.
Samadi A; de los Ríos C; Bolea I; Chioua M; Iriepa I; Moraleda I; Bartolini M; Andrisano V; Gálvez E; Valderas C; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2012 Jun; 52():251-62. PubMed ID: 22503231
[TBL] [Abstract][Full Text] [Related]
16. Tetrahydroacridine derivatives with fluorobenzoic acid moiety as multifunctional agents for Alzheimer's disease treatment.
Czarnecka K; Szymański P; Girek M; Mikiciuk-Olasik E; Skibiński R; Kabziński J; Majsterek I; Malawska B; Jończyk J; Bajda M
Bioorg Chem; 2017 Jun; 72():315-322. PubMed ID: 28501648
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
[TBL] [Abstract][Full Text] [Related]
18. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
